Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Holoxica is a private UK technology company developing holographic 3D visualization products and software for medical imaging, telemedicine, surgical planning, education, and other industrial use cases. The company originated from founder Javid Khan's doctoral research in holographic displays and has built proprietary software and display technologies spanning digital holograms, volumetric displays, and light-field visualization. In healthcare, Holoxica markets applications such as Holoviewer, HoloSlicer/Volumeviewer, and a broader Holo-Medicine suite designed to convert CT, MRI, ultrasound, and X-ray data into interactive 3D visualizations for clinicians and patients. Its business appears to be centered on commercial software, consulting, prototyping, and licensing of holographic visualization technology rather than drug development. Holoxica therefore fits best as a healthtech/medtech platform company serving visualization and workflow needs in healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holoxica.